老虎证券

美股详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Lineage Cell Therapeutics Inc

1.01
-0.0100-0.98%
盘后：1.020.0100+0.99%16:51 EDT
成交量：91.26万
成交额：92.63万
市值：2.31亿
市盈率：-13.15
高：1.06
开：1.04
低：0.9930
收：1.02
数据加载中...
总览公司新闻资讯公告
2020/04/28

[修订]年度报告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2020/04/27

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2020/03/12

年度报告

Annual report [Section 13 and 15(d), not S-K Item 405]
2020/03/12

重要事件披露

Current report, items 2.02 and 9.01
2020/02/14

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2020/01/13

重要事件披露

Current report, items 7.01 and 9.01
2020/01/06

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/11/12

季度报告

Quarterly report [Sections 13 or 15(d)]
2019/11/12

重要事件披露

Current report, items 2.02 and 9.01
2019/10/18

重要事件披露

Current report, item 8.01
2019/10/15

重要事件披露

Current report, items 8.01 and 9.01
2019/09/19

重要事件披露

Current report, items 8.01 and 9.01
2019/09/13

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/08/15

持股变动声明

Statement of changes in beneficial ownership of securities
2019/08/15

持股变动声明

Statement of changes in beneficial ownership of securities
2019/08/15

持股变动声明

Statement of changes in beneficial ownership of securities
2019/08/15

持股变动声明

Statement of changes in beneficial ownership of securities
2019/08/12

重要事件披露

Current report, items 5.03, 8.01, and 9.01
2019/08/08

员工持股计划

Securities to be offered to employees in employee benefit plans
2019/08/08

季度报告

Quarterly report [Sections 13 or 15(d)]
更多